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Corticobasal degeneration (CBD) is an adult-onset progressive movement disorder with cortical and basal ganglionic dysfunction. 1 Typical clinical symptoms include asymmetric rigidity, bradykinesia, dystonia, myoclonus, dyspraxia, and cortical sensory loss, along with gait disorder and dementia. PET studies showed consistent asymmetric cerebral hypometabolism contralateral to the most affected body side, but intrahemispheric hypometabolism was found in many and various regions. [2] [3] [4] However, voxel-based statistical comparisons 5, 6 suggest that cortical metabolic impairment in CBD predominates in perirolandic and adjacent premotor and parietal regions, known to be involved in movement production.
Upper limb apraxia is reputedly a core symptom to distinguish CBD from other degenerative diseases. 7, 8 In an attempt to characterize more precisely the gestural impairment associated with CBD, two group studies concluded that ideomotor apraxia is the most typical feature. 9, 10 However, other case studies emphasized predominant melokinetic apraxia in CBD. 11, 12 However, these classifications did not provide information about the impaired cognitive mechanisms that underlie limb apraxia in CBD; hence further studies tried to interpret the neuropsychological deficits seen in patients with CBD in the light of cognitive models of apraxia. Current models 13, 14 posit that at least two main components are involved in normal praxis processing: the conceptual system, which provides an abstract representation of the action, and the production system, which incorporates both the sensorimotor knowledge of the action and the perceptivomotor processes needed for its organization and execution. In this background, a lack of control of spatial and temporal aspects during gesture execution, found in three patients with CBD, 15 demonstrated an impairment of the production system. Similarly, a productionexecution defect was found along with a relative Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the October 9 issue to find the title link for this article.
sparing of movement representations in three patients with CBD who did not have dementia. 16 These results refined previous findings in noting a deficit in the stages of movement production but failed to agree on the anatomic basis of the apraxic disorder in CBD. Few patients were involved in these latter studies, however, and little is known about the interindividual heterogeneity of the apraxic symptoms in CBD.
In the present study, a detailed neuropsychological assessment of upper limb apraxia was conducted in 18 patients with CBD. Results were compared with regard to the normal distribution of praxic performance in healthy age-matched controls, using two measures that reflect different but complementary cognitive contributions to the gestural impairment. Additionally, resting brain regional metabolism was estimated in patients with CBD using the [ 18 F]-fluorodeoxyglucose PET technique. Metabolism comparisons between patients who performed in the normal range and patients with apraxic behavior were conducted to further characterize the neural substrate of the different processes underlying upper limb apraxia in CBD.
Methods. Eighteen right-handed patients (12 women and 6 men; mean age, 64 Ϯ 8.8 years) gave their informed consent to participate in the present study approved by the Ethical Committee of the Faculty of Medicine of the University of Liège. Clinically probable CBD was diagnosed by two experienced neurologists, according to international descriptions. 7 Insidious onset and gradual progression of an asymmetric levodopa-resistant akinetic-rigid syndrome, with or without other basal ganglia features, were the main clinical symptoms. Other clinical signs are summarized in table 1. Mean onset of symptoms was 3.1 Ϯ 2.2 years. Motor disturbance was more pronounced in the right body side in eight patients and in the left body side in 10 patients. Fifteen healthy right-handed age-matched volunteers (eight men and seven women; 68.4 Ϯ 8.4 years) 
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constituted the control group for apraxia assessment. Because PET scanning could not be performed in the control group, metabolic data obtained in patients with CBD were compared with those of another cohort of 20 age-matched healthy right-handed subjects (14 men and 6 women; 61.3 Ϯ 1.8 years), from a database previously built in the laboratory. Mean age did not differ between any of the three groups (ps Ͼ 0.23).
Upper limb apraxia assessment. Upper limb apraxia was assessed using a shortened version of the "Batterie d'Evaluation des Praxies." 17 Adapted from cognitive approaches, 14, 18 the Batterie d'Evaluation des Praxies is built on a modeling that proposes to account for the large array of task-and gesture-related dissociations of performance reported in the apraxia literature 14 (e.g., pantomime to command vs gesture imitation or meaningless vs meaningful gestures imitation). It assumes that normal gesture processing relies on a set of dedicated processing units acting at various levels: perceptual auditory, object-visual, or gestural-visual analysis; representational input and output lexicons (i.e., where spatiotemporal engrams for perception and production of movements are stored); conceptual action semantic system; body knowledge mediation for meaningless gesture imitation; and innervatory patterns for movement implementation.
Gesture production. We tested the less affected limb only in patients with CBD and both limbs in control subjects.
Pantomime to verbal command and imitation. Sixty gestures were performed with each limb, including 20 meaningful gestures administered both in verbal (pantomime to verbal command [PVe] ) and imitation (meaningful gestures imitation [IMf] ) modalities, and 20 meaningless gestures administered in imitation modality only (meaningless gestures imitation [IMs] ). Meaningless and meaningful gestures were individually matched based on upper limb components recruited (whole limb or hand/finger complex), movement kinematic (dynamic or static gesture), and global complexity. Gestures were administered in a randomized fashion. Instructions emphasized maximal accuracy during gesture production. For pantomime to command, subjects were instructed to perform transitive gestures "as if they really held the tool" (e.g., they were supposed to keep enough space between fingers for holding a hammer, or between hand and teeth for toothbrush use). For imitation tasks, they were instructed to watch very carefully the examiner's demonstration "in order to reproduce exactly the same arm, hand, and finger movements and positions"; imitation was allowed only after completion of the examiner's demonstration. In all modalities, a second trial was administered in case of defective gesture production, with the instruction to improve the performance as much as possible. Two examples in each modality (not presented during the testing session) were given to ensure the subject's awareness of the high degree of accuracy that was required during gesture production.
Pantomime to object. In pantomime to object (POb), 12 pictures of familiar transitive objects (e.g., comb, pen) were presented, with the instruction to pantomime the gesture corresponding to their use. Procedure and instructions emphasizing accuracy were the same as in the preceding section.
Actual use of objects. The 12 objects pictured in the POb condition were placed on a table, one at a time. Subjects were requested to handle the object and to show its use as best as possible. For all conditions, the examination was videotaped for subsequent scoring by two independent examiners. Each gesture was scored using a multidimensional qualitative analysis system, 17 adapted from previous studies, 19 which differentiates 16 error types belonging to three main supracategories. In short, typical content or action semantic errors are well-performed but ill-selected gestures (e.g., pretending to use a hammer when instructed to play piano) or perseverative responses. Temporal errors reflect action sequencing deficits (e.g., to omit, transpose, or add movement elements in the course of an action) or failure to regulate a movement's timing (e.g., abnormally split movements). Finally, spatial errors are predominantly characterized by inaccurate positioning of the hand in space (e.g., to put the hand on the back of the head when imitating a military salute), wrong finger configuration (e.g., a hand configuration inaccurate to hold the object pretended to be used), inaccurate movement amplitude, or disturbances of the core characteristics of the movement (e.g., because rotation at the elbow is the core movement feature when using a screwdriver, rotation at the shoulder with the elbow stabilized will be an error). Interexaminer scoring discrepancies were debated in a subsequent phase until they reached an agreement.
Each error was reported as a simple (S) or a consistent (C) error for each gesture. A simple error is an error accurately corrected on the second attempt to perform the gesture, and a consistent error is repeated despite the examiner's reinstruction to improve performance. Two scores were computed that reflected distinct aspects of the subjects' apraxic behavior. The performance score is the percentage of gestures correctly performed on the first trial, computed globally, in each error category and in each modality of interest. The correction score is the proportion of corrected errors ([S/{S ϩ C}]), computed globally, in each error category and in each modality of interest. Note that performance and correction scores are complementary sources of information with respect to the state of the praxic system. The performance score is a global measure of the frequency of errors during gesture production but does not allow determination of whether these apraxic errors originated from deficits that are specific to the cognitive units dedicated to normal praxic processing, or from the alteration of unspecific cognitive components. The correction score does not measure the prevalence of errors but is more likely to reflect the integrity of the praxic system. Indeed, the ability to correct an error means that the cognitive components needed to achieve a correct performance are relatively well preserved, even if difficult to access. Therefore, an error observed only on the first attempt is likely to be due to the impairment of cognitive components that are not truly specific to gestural processing (e.g., attentional or working memory deficits). Methodologically speaking, the proportion of errors accurately corrected after reinstruction is the most valid indicator of the pathologic status of these errors because this proportion is independent of the overall frequency of errors. 17 Finally, we accounted for the established fact that variability of gestural processing measures in brain-damaged patients partly reflects the interindividual variability seen in normal subjects. 20 Hence, diagnosis of apraxia must be established with reference to the extent of the distribution of these measures in normal subjects. In this respect, we defined the cut-off score under which apraxia could be diagnosed in each patient with CBD as the minimal global (across all modalities and categories) performance or correction score observed across the control population. These cut-off scores served as group selection criteria for the PET analyses described hereafter.
Gesture reception. Subjects watched a videotaped demonstration of 30 upper limb unimanual and bimanual gestures (15 meaningful and 15 matched meaningless) and were instructed that two types of gestures could be displayed: "known" and "unknown." They were told that known gestures were pantomimes of object use or communicative movements (e.g., salute), with obvious meaning. Conversely, unknown gestures were nonsignificant in this respect, even if they sometimes resembled known gestures. Subjects were instructed to name known gestures or to mention it if they were sure that the gesture was meaningful but could not retrieve its name. A discrimination score was computed as the percentage of correct category attributions (known vs unknown) across the 30 gestures, and a recognition score was derived as the percentage of correct naming for the 15 meaningful gestures.
Additional testing. Additional neuropsychological data were obtained in the CBD group only. Semantic, phonemic, and alternated verbal fluencies, WI Card Sorting Test (WCST), Stroop test, trail making test, digit span, and visuospatial sequential span (Corsi blocks) were administered. Results were compared between subgroups to control to what extent the performance in particular domains of cognition could differ between patients with CBD with and without apraxia, as defined with regard to correction and performance scores.
Statistics. Between-groups comparisons were run using Mann-Whitney U test for independent samples, within-group multiple comparisons using Friedman analysis of variance (ANOVA), and within-group paired comparisons using Wilcoxon test for dependent samples. Nonsignificant differences in paired comparisons were verified by subsequent power analyses. 21 Significance threshold was set at p Ͻ 0.05, further corrected using the Bonferroni correction for multiple comparisons in betweengroup analyses.
PET. Data acquisition. PET scans were obtained during quiet wakefulness with eyes closed using a Siemens 951/31R tomograph (CTI, Knoxville, TN) and the [
18 F]-fluorodeoxyglucose PET technique. 22 A transmission scan was performed before the emission scanning to allow measured attenuation correction. Seven mCi of fluorodeoxyglucose were injected IV. Acquisition started 35 minutes after injection. Scan duration was 20 minutes. Data were reconstructed using a Hanning filter at a cut-off frequency of 0.5 cycle/pixel, giving a transaxial resolution of 8.7 mm full width at half maximum (FWHM), and an axial resolution of 5 mm FWHM for each of 31 planes, with a total field of view of 10.8 cm in the axial direction.
Data analysis. Metabolic data were analyzed using SPM99 software (Wellcome Department of Cognitive Neurology, Institute of Neurology, London) implemented in MATLAB (Mathworks, Sherborn, MA). We flipped scans of patients with CBD with clinical signs predominant on the left body side (see table 1) so that the hemisphere contralateral to the most affected body side was on the left in all CBD cases. 6 Data were then normalized into a standard stereotactic space and smoothed using a 12-mm FWHM isotropic kernel. Digitized structural T1-weighted MRI, available for 13 patients, were normalized into the same standard stereotactic space as functional PET images to check the results of analyses on the individual gyral anatomy of patients with CBD. Spatial registration and normalization of images conform to the space defined by the International Consortium for Brain Mapping, NIH p Ϫ 20 project and approximate to that of standard stereotaxic atlas. 23 Areas of significant change between conditions of interest were estimated according to the general linear model using linear contrasts; global metabolism adjustment was performed using proportional scaling. The primary contrast estimated the main effect of pathology (control subjects vs patients with CBD), to identify the brain regions where the glucose metabolism was decreased in the CBD population as compared with the control cohort. In a second step, the condition effects were assessed within the CBD population (CBD nonapraxic vs CBD apraxic, categorized regarding either global performance or correction cut-off scores), to identify brain areas where glucose metabolism was decreased as a function of the presence of apraxia in CBD. The analysis was masked inclusively (p Ͻ 0.001, uncorrected) by the main effect of pathology; i.e., the statistical comparisons were constrained to the brain regions metabolically impaired in CBD. The resulting set of voxel values for each contrast constituted a map of the T statistics (SPM[T]), thresholded at p Յ 0.001 (T Ն 3.35), uncorrected. Minimal spatial extent of reported brain areas is 50 contiguous significant voxels.
Results.
Upper limb apraxia assessment. Pantomime to object and actual use of objects (UOb) conditions could not be performed in four cases. Preliminary analyses failed to disclose statistical differences between patients with CBD with predominant left and right body side motor symptoms, regarding the limb used for testing whatever the gesture production condition and the score type. No differences were found between left and right hand for gesture production in the control population. Data obtained for both hands were therefore pooled as summarized in table 2.
Gesture production. Mean performance scores (i.e., the percentage of gestures correctly performed on the first trial) were computed globally and in each condition (see table 2 ). Global mean performance score was lower in the CBD population than in the control group (p Ͻ 0.001). Between-group differences were disclosed in PVe, IMf, and IMs conditions (ps Ͻ 0.001), but not in the POb condition (p ϭ 0.13). However, a subsequent power analysis showed that the score differences between groups yielded a medium effect size (0.48) and that a sample size of 68 would be sufficient to reach a power level of 0.80 in this latter condition. Hence, the hypothesis that CBD group performance for POb condition is different from control group performance cannot be confidently rejected. Statistical comparison in UOb condition was precluded because all control subjects scored 100%, but note that 11 of 14 patients with CBD also reached the maximal performance score.
Separate Friedman ANOVA disclosed that performance scores differ between matched conditions (PVe, IMf, IMs) in both CBD and control groups (ps Ͻ 0.001). Paired comparisons showed that IMs performance score was lower than both PVe and IMf scores in the control group (ps Ͻ 0.001); PVe and IMf performance scores did not differ (p Ͼ 0.33). In the CBD population, both imitation conditions yielded similar performance scores (IMf vs IMs; p Ͼ 0.12), and PVe condition was performed better than the two other conditions (ps Ͻ 0.001). Hence, control subjects performed as well for meaningful gestures in both verbal command and imitation conditions, but their performance decreased for meaningless items, whereas patients with CBD were more impaired when imitating gestures irrespective of their meaning.
Regarding the error types committed during gesture production irrespective of the condition, the CBD population obtained lower performance scores than the control group in all supracategories (ps Ͻ 0.005; see table 2). Friedman ANOVA between conceptual, temporal, and spatial supracategories disclosed differences in both CBD and control groups (ps Ͻ 0.001). Paired comparisons evidenced a similar pattern in both groups, with a slight but significant decrease in performance between supracategories (conceptual Ͼ temporal Ͼ spatial; ps Ͻ 0.001).
Mean correction scores (i.e., the proportion of corrected errors) computed globally and in each condition are displayed in table 2. Global mean correction score differed between CBD and control populations (p Ͻ 0.001). Between-group differences were disclosed in meaningful [IMf] and meaningless [IMs] gesture imitation conditions (ps Ͻ 0.005), but not in PVe (p Ͼ 0.15) and POb (p Ͼ 0.75) conditions. Friedman ANOVA failed to disclose correction score differences between matched conditions (PVe, IMf, IMs) in both CBD and control groups (ps Ͼ 0.6).
Regarding the error types irrespective of the condition, the CBD population obtained lower correction scores in all supracategories (ps Ͻ 0.005; see table 2). Friedman ANOVA between conceptual, temporal, and spatial supracategories disclosed differences in both CBD and control groups (ps Ͻ 0.005), but paired comparisons showed a different distribution of correction scores between supracategories in these populations. Indeed, patients with CBD were markedly more impaired in correcting temporal than conceptual and spatial errors (ps Ͻ 0.005), whereas subjects in the control population corrected spatial errors worse than other error categories (ps Ͻ 0.005). Conceptual errors were better corrected than other error types in both CBD and control groups (ps Ͻ 0.05).
Finally, we analyzed interindividual variability in CBD and control groups. Global performance scores ranged from 0.21 to 0.84 (CBD) and 0.51 to 0.92 (control). Global correction scores ranged from 0.15 to 0.61 (CBD) and 0.22 to 1.00 (control). Cut-off score for upper limb apraxia was defined as the minimal global score observed across the control population, for the same body side as tested in patients with CBD. When apraxia was defined with regard to the performance cut-off score (right hand ϭ 0.64, left hand ϭ 0.51), 14 patients were found apraxic of 18 with CBD. At variance, only seven of 18 patients with CBD were found apraxic when apraxia was defined with regard to the correction cut-off score (right hand ϭ 0.22, left hand ϭ 0.32).
Gesture reception. Differences between groups were moderate but significant. Mean discrimination scores (i.e., percentage of correct category attributions) were 0.87 (SEM ϭ 0.03) for the CBD population and 0.99 (0.01) for the control group (p Ͻ 0.0005). Mean recognition scores (i.e., percentage of correct naming) were 0.80 (0.04) for CBD and 0.99 (0.01) for control (p Ͻ 0.0001).
Additional testing. Additional testing could not be obtained in four cases. When apraxia was defined with regard to the performance score, no differences were found between patients with CBD with and without apraxia for any of the executive tasks (ps Ͼ 0.09). When apraxia was defined with regard to the correction score, a significant difference was found between patients with CBD with and Table of Contents to find the title link for this article). Results are reported as ipsilateral or contralateral to the clinically most affected body side. Regional metabolic decrease in patients with CBD was more pronounced in the contralateral brain hemisphere (figure 1). The hypometabolism was bilateral in the frontal lobe including premotor cortex and supplementary motor area (SMA), in the underlying dorsal cingulate area and the adjacent pre-SMA and prefrontal cortex, in the precentral gyrus, and in the anterior superior temporal cortex close to the insula. In addition, contralateral hypometabolism was found in the postcentral gyrus, in the inferior/superior parietal lobule, in the dorsomedial thalamus, and in the lateral globus pallidus.
With regard to the specificity of the global performance and correction scores, regional glucose metabolism comparison between patients with apraxia and patients without apraxia was intended to show brain areas where metabolic impairment contributes to the apraxic behavior in CBD (table 3) . When apraxia was defined with regard to the performance score, the subtraction analysis disclosed regional hypometabolism in patients with apraxia in the anterior cingulate cortex (figure 2), encroaching on corpus callosum. Further inspection on individual normalized MRI indicates that the hypometabolism actually predominated in the cingulate (Brodmann area 24), in the caudal supracallosal part of the anterior cingulate cortex. 24 A tentative group (CBD patients with apraxia vs CBD patients without apraxia) by imaging modality (PET vs MRI) interaction analysis, 25 conducted in the 13 patients with CBD who had undergone both PET and MRI scanning, suggested that the observed hypometabolism could not be merely explained by gray matter loss in the cingulate region of patients with CBD with apraxia.
At variance, when apraxia was defined with regard to the correction score, hypometabolic loci were found (see figure 2 ) contralateral to the most affected body side in patients with apraxia, in the superior parietal lobule close to the intraparietal sulcus, in the medial frontal gyrus (and SMA), and in the middle frontal gyrus close to the superior frontal sulcus. Additional ipsilateral hypometabolism was found in the precentral gyrus. At a lower statistical threshold (p Ͻ 0.005), ipsilateral hypometabolism was also found in the superior parietal lobule and intraparietal sulcus.
Discussion. Several considerations should restrict the interpretation of the results reported here. First, it is important to stress that CBD was a clinical diagnosis not confirmed by necropsy. Both the sensitivity and the specificity of the CBD diagnosis are debated, 26 ,27 so we cannot exclude the presence of other neurodegenerative syndromes. At least, the patients included in the present study presented a fairly homogeneous clinical syndrome consistent with the classic form of clinically probable CBD. Second, PET data were obtained at rest, not during gesture processing. It must be emphasized that an association between resting fluorodeoxyglucose values and behavioral measures did not prove that the regions abnormal at rest are involved in the networks responsible for the behavior. Therefore, our results merely point to a possible dysfunctional role of specific brain regions in limb praxis processing in probable CBD, which may be confirmed by brain imaging activation studies and neuropsychological reports. Finally, the wide normal variability in limb gesturing 20 remains a challenging issue for the assessment of the neural bases of limb apraxia in CBD. Here, correlational analyses between behavioral indices and PET findings were discarded in favor of a categorical approach (apraxic vs nonapraxic patients with CBD). This was intended to better control the effects of normal gesturing variability, to enhance the power to detect apraxia-related regional metabolic differences.
Lowered performance scores (i.e., the frequency of gestural errors) of patients with CBD in all matched conditions demonstrate an impairment in movement production, which may originate from disruption of true praxis processing components or from other cognitive deficits such as reduced attentional capacities or memory deficits. In addition, production of gestures on imitation is more impaired than production of the same gestures on verbal command. The correction score, reflecting patients' ability to correct their error on a second trial, is a more stringent test of the actual state of the components of the praxic system, because it takes into account the fact that gestural errors could be made fortuitously. Correction scores were below the normal range for imitation conditions only. Hence, the combination of both impaired performance scores and impaired correction scores only for imitation tasks indicates that specific cognitive components required to achieve a correct visuoimitative performance must be impaired or disrupted in the gestural system. Gesture reception is not preserved either. Even if reception impairment was only slight compared with gesture production deficit, patients with CBD fell below control scores in discrimination and recognition tasks.
In the theoretical framework of our cognitive model of apraxia, 17 the processing pathways involved in meaningful and in meaningless gesture imitation share the demonstrated gesture's input to the visuogestural analysis module and the gestural information output through innervatory patterns for motor response implementation. PVe overlaps with both imitation conditions in that every process needs to access innervatory patterns for movement production. Because performance scores in the CBD population are impaired in all modalities, this suggests a disruption at a common output stage of the praxic system, i.e., an impairment of the innervatory patterns, as suggested by previous studies. 15, 16 Moreover, correction scores were more impaired for the temporal supracategory than for other supracategories in patients with CBD, and predominant errors in the temporal category were movement timing regulation failures. In addition to elementary motor and sensory causes, such a deficit could originate from a disruption at either the output gestural lexicon or the innervatory patterns stages. 19 Hence, the qualitative analysis of the errors also supports the hypothesis of an impairment of the innervatory patterns stage. Conversely, because imitation was more impaired than PVe, an additional disruption must be found in components that are involved in imitation but not in PVe processing. Impaired performance of patients with CBD in gesture reception strengthens this hypothesis, because discrimination and recognition of gestures are nonmotor processes that do not involve activation of the innervatory patterns module. This additional impairment is likely due to visuogestural analysis alteration or defective transfer at or after its output, because this stage is shared by gesture imitation and recognition.
Previous studies have demonstrated an impairment in gesture production in CBD 9,10,15,16 but did not emphasize differences between production modalities or visuoimitative apraxia. For some cases, this could originate from lack of sensitivity of the quantitative scoring systems used for apraxia evaluation. An additional difference between our investigation and previous studies 9, 15, 16 is that we found gesture discrimination and recognition impaired in patients with CBD. Patients with CBD scored 80 to 90% correct for gesture recognition in prior studies, 9,16 which was not interpreted as an impairment. Most of our patients with CBD scored in a similar range in the present study, but healthy age-matched subjects performed the gesture reception tasks perfectly, which suggests that CBD performance is nevertheless abnormal even if reception impairment is only mild.
Compared with healthy controls, patients with CBD showed an asymmetric pattern of cortical and subcortical hypometabolism, in agreement with the clear-cut contralateral asymmetry of clinical signs seen in individual cases (see table 1 ). Asymmetric hypometabolism in sensorimotor, premotor, and parietal areas is compatible with a functional impairment of the neural networks involved in movement production in CBD 6 and in the occurrence of various limb apraxic symptoms. 29, 30 In our attempt to further characterize the brain networks whose deficits underlie limb apraxia in CBD, we compared patients with and without apraxia according to the specificity of performance and correction scores. Damages in distinct neural structures seemed to underlie separate facets of the apraxic-type gestural processing deficits in CBD. We found anterior cingulate metabolic decrease in patients with CBD whose performance score was below normal range. As a part of a distributed network, the cognitive anterior cingulate cortex is involved in visual-spatial 31, 32 or supervisory-executive 33, 34 attention and conflict monitoring 35 or when task difficulty, motor output, and recent memory requirements must be combined. 28 However, the use of the correction score is a more stringent test of the integrity of the components of the praxic system. When apraxia was defined with reference to the correction score, we showed superior parietal lobule and SMA hypometabolism in apraxic patients with CBD. These areas are described in the monkey as regions being part of the multiple parallel parietofrontal circuits devoted to sensorimotor transformations. 36 In humans, these are hypothesized to be similarly involved in the transformation of sensory information into action. 37 Damage to these systems is likely to produce different types of limb apraxic deficits depending on the injured site, the context in which the movement is performed, and the cognitive demands of the action. 29, 30 Superior parietal lobule involvement was hypothesized in visually guided movements, 38, 39 mental transformations of the body in space, 40 elaboration and maintenance of working representation of the gesture to perform, 41 and successful integration of internal and external representations to direct action. 42, 43 Also, the superior parietal lobule was found hypometabolic in a case of visuoimitative apraxia. 44 However, the presence of visuospatial span differences between patients with and patients without apraxia did not allow ruling out the possibility that a more general visuospatial impairment contributes to the finding of a parietal hypometabolism in patients with apraxia. Concerning a possible visuogestural analysis deficit, which might explain visuoimitative symptoms, PET data suggest that neural activity in the lateral occipitotemporal junction underlies this process. 45 Because occipitotemporal junction was not metabolically impaired in our CBD population, this rather suggests that abnormal correction scores for imitation conditions are partly due to defective transfer or integration of close to normal visuogestural information in the superior parietal lobule. A problem arising after visuogestural analysis might also explain why recognition of gestures is only slightly corrupted, because less information is needed to identify a gesture than to accurately implement its reproduction.
Using the correction score, we found also premotor and SMA dysfunction in patients with CBD who had apraxia. Presumably, SMA is in charge of transcoding stored space-time representations of movement into limb innervatory patterns.
14 Several studies hypothesize that SMA dysfunction underlies limb apraxia features in CBD, 10, 15, 16 but a similar role has been devoted to the lateral premotor cortex 16, 46 or to the parietal and central regions. 11, 12 Only a few studies have reported clear cases of ideomotor apraxia with premotor 47, 48 and SMA 49, 50 lesions, a paucity tentatively explained by the fact that a defect caused by a unilateral dominant premotor lesion may be compensated by the contralateral hemisphere, 29 due to close interactions between the two frontal lobes during the performance of a unilateral movement. 51 In the present study, however, the hypometabolism was bilateral in premotor regions when patients with CBD were compared with normal controls. It is therefore likely that deficiencies in one hemisphere cannot be compensated by the activity of the other hemisphere in CBD, as expected in the case of strictly unilateral focal lesions.
